Nations Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,657
| Closed | -$530K | – | 628 |
|
|
2023
Q3 | $530K | Buy |
7,657
+815
| +12% | +$56.5K | 0.05% | 352 |
|
|
2023
Q2 | $645K | Sell |
6,842
-51
| -0.7% | -$4.81K | 0.06% | 324 |
|
|
2023
Q1 | $570K | Buy |
6,893
+226
| +3% | +$18.7K | 0.06% | 342 |
|
|
2022
Q4 | $497K | Buy |
6,667
+13
| +0.2% | +$970 | 0.06% | 359 |
|
|
2022
Q3 | $550K | Sell |
6,654
-481
| -7% | -$39.8K | 0.08% | 275 |
|
|
2022
Q2 | $678K | Buy |
7,135
+9
| +0.1% | +$855 | 0.09% | 239 |
|
|
2022
Q1 | $839K | Sell |
7,126
-1,705
| -19% | -$201K | 0.1% | 220 |
|
|
2021
Q4 | $1.14M | Sell |
8,831
-21
| -0.2% | -$2.72K | 0.15% | 160 |
|
|
2021
Q3 | $1M | Buy |
8,852
+3,168
| +56% | +$359K | 0.15% | 167 |
|
|
2021
Q2 | $589K | Buy |
5,684
+58
| +1% | +$6.01K | 0.1% | 235 |
|
|
2021
Q1 | $471K | Buy |
5,626
+490
| +10% | +$41K | 0.11% | 224 |
|
|
2020
Q4 | $469K | Buy |
5,136
+395
| +8% | +$36.1K | 0.12% | 204 |
|
|
2020
Q3 | $378K | Sell |
4,741
-230
| -5% | -$18.3K | 0.12% | 207 |
|
|
2020
Q2 | $344K | Buy |
4,971
+294
| +6% | +$20.3K | 0.12% | 197 |
|
|
2020
Q1 | $294K | Buy |
4,677
+273
| +6% | +$17.2K | 0.13% | 194 |
|
|
2019
Q4 | $342K | Sell |
4,404
-2,358
| -35% | -$183K | 0.12% | 214 |
|
|
2019
Q3 | $537K | Buy |
+6,762
| New | +$537K | 0.19% | 159 |
|